These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 21734182)

  • 21. Mutations in the glucocerebrosidase gene are common in patients with Parkinson's disease from Eastern Canada.
    Han F; Grimes DA; Li F; Wang T; Yu Z; Song N; Wu S; Racacho L; Bulman DE
    Int J Neurosci; 2016; 126(5):415-21. PubMed ID: 26000814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of glucocerebrosidase mutations on motor and nonmotor complications in Parkinson's disease.
    Oeda T; Umemura A; Mori Y; Tomita S; Kohsaka M; Park K; Inoue K; Fujimura H; Hasegawa H; Sugiyama H; Sawada H
    Neurobiol Aging; 2015 Dec; 36(12):3306-3313. PubMed ID: 26422360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study.
    Alcalay RN; Caccappolo E; Mejia-Santana H; Tang M-; Rosado L; Orbe Reilly M; Ruiz D; Ross B; Verbitsky M; Kisselev S; Louis E; Comella C; Colcher A; Jennings D; Nance M; Bressman S; Scott WK; Tanner C; Mickel S; Andrews H; Waters C; Fahn S; Cote L; Frucht S; Ford B; Rezak M; Novak K; Friedman JH; Pfeiffer R; Marsh L; Hiner B; Siderowf A; Payami H; Molho E; Factor S; Ottman R; Clark LN; Marder K
    Neurology; 2012 May; 78(18):1434-40. PubMed ID: 22442429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A "dose" effect of mutations in the GBA gene on Parkinson's disease phenotype.
    Thaler A; Gurevich T; Bar Shira A; Gana Weisz M; Ash E; Shiner T; Orr-Urtreger A; Giladi N; Mirelman A
    Parkinsonism Relat Disord; 2017 Mar; 36():47-51. PubMed ID: 28012950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive impairment in Glucocerebrosidase (GBA)-associated PD: Not primarily associated with cerebrospinal fluid Abeta and Tau profiles.
    Lerche S; Schulte C; Srulijes K; Pilotto A; Rattay TW; Hauser AK; Stransky E; Deuschle C; Csoti I; Lachmann I; Zetterberg H; Liepelt-Scarfone I; Gasser T; Maetzler W; Berg D; Brockmann K
    Mov Disord; 2017 Dec; 32(12):1780-1783. PubMed ID: 29094781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Motor laterality asymmetry and nonmotor symptoms in Parkinson's disease.
    Cubo E; Martín PM; Martin-Gonzalez JA; Rodríguez-Blázquez C; Kulisevsky J;
    Mov Disord; 2010 Jan; 25(1):70-5. PubMed ID: 20014110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of pre-diagnostic symptoms did not differ between LRRK2-related, GBA-related and idiopathic patients with Parkinson's disease.
    Liu SY; Zheng Z; Gu ZQ; Wang CD; Tang BS; Xu YM; Ma JH; Zhou YT; Feng T; Chen SD; Chan P;
    Parkinsonism Relat Disord; 2018 Dec; 57():72-76. PubMed ID: 30119933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical profiles of Parkinson's disease associated with common leucine-rich repeat kinase 2 and glucocerebrosidase genetic variants in Chinese individuals.
    Wang C; Cai Y; Gu Z; Ma J; Zheng Z; Tang BS; Xu Y; Zhou Y; Feng T; Wang T; Chen SD; Chan P;
    Neurobiol Aging; 2014 Mar; 35(3):725.e1-6. PubMed ID: 24095219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative Transcriptome Analysis in Monocyte-Derived Macrophages of Asymptomatic
    Usenko T; Bezrukova A; Basharova K; Panteleeva A; Nikolaev M; Kopytova A; Miliukhina I; Emelyanov A; Zakharova E; Pchelina S
    Genes (Basel); 2021 Sep; 12(10):. PubMed ID: 34680941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between Parkinson's disease and glucocerebrosidase mutations in Brazil.
    Spitz M; Rozenberg R; Pereira Lda V; Reis Barbosa E
    Parkinsonism Relat Disord; 2008; 14(1):58-62. PubMed ID: 17703984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcranial sonography and functional imaging in glucocerebrosidase mutation Parkinson disease.
    Barrett MJ; Hagenah J; Dhawan V; Peng S; Stanley K; Raymond D; Deik A; Gross SJ; Schreiber-Agus N; Mirelman A; Marder K; Ozelius LJ; Eidelberg D; Bressman SB; Saunders-Pullman R;
    Parkinsonism Relat Disord; 2013 Feb; 19(2):186-91. PubMed ID: 23062841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Penetrance of Parkinson disease in glucocerebrosidase gene mutation carriers.
    Anheim M; Elbaz A; Lesage S; Durr A; Condroyer C; Viallet F; Pollak P; Bonaïti B; Bonaïti-Pellié C; Brice A;
    Neurology; 2012 Feb; 78(6):417-20. PubMed ID: 22282650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical phenotype of drug-naïve Parkinson's disease based on nonmotor symptoms.
    Lee HM; Lee SS; Kim M; Kang SH; Seo WK; Kim JH; Koh SB
    Arch Gerontol Geriatr; 2015; 61(3):517-22. PubMed ID: 26183203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survival and dementia in GBA-associated Parkinson's disease: The mutation matters.
    Cilia R; Tunesi S; Marotta G; Cereda E; Siri C; Tesei S; Zecchinelli AL; Canesi M; Mariani CB; Meucci N; Sacilotto G; Zini M; Barichella M; Magnani C; Duga S; Asselta R; Soldà G; Seresini A; Seia M; Pezzoli G; Goldwurm S
    Ann Neurol; 2016 Nov; 80(5):662-673. PubMed ID: 27632223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contribution of glucocerebrosidase mutation in a large cohort of sporadic Parkinson's disease in Taiwan.
    Huang CL; Wu-Chou YH; Lai SC; Chang HC; Yeh TH; Weng YH; Chen RS; Huang YZ; Lu CS
    Eur J Neurol; 2011 Oct; 18(10):1227-32. PubMed ID: 21338444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of the glucocerebrosidase gene in Parkinson's disease.
    Sato C; Morgan A; Lang AE; Salehi-Rad S; Kawarai T; Meng Y; Ray PN; Farrer LA; St George-Hyslop P; Rogaeva E
    Mov Disord; 2005 Mar; 20(3):367-70. PubMed ID: 15517592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prodromal substantia nigra sonography undermines suggested association between substrate accumulation and the risk for GBA-related Parkinson's disease.
    Arkadir D; Dinur T; Becker Cohen M; Revel-Vilk S; Tiomkin M; Brüggemann N; Cozma C; Rolfs A; Zimran A
    Eur J Neurol; 2019 Jul; 26(7):1013-1018. PubMed ID: 30714262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical, genetic, and brain sonographic features related to Parkinson's disease in Gaucher disease.
    Böttcher T; Rolfs A; Meyer B; Grossmann A; Berg D; Kropp P; Benecke R; Walter U
    J Neurol; 2013 Oct; 260(10):2523-31. PubMed ID: 23811968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucocerebrosidase mutations influence the natural history of Parkinson's disease in a community-based incident cohort.
    Winder-Rhodes SE; Evans JR; Ban M; Mason SL; Williams-Gray CH; Foltynie T; Duran R; Mencacci NE; Sawcer SJ; Barker RA
    Brain; 2013 Feb; 136(Pt 2):392-9. PubMed ID: 23413260
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GBA-Related Parkinson's Disease: Dissection of Genotype-Phenotype Correlates in a Large Italian Cohort.
    Petrucci S; Ginevrino M; Trezzi I; Monfrini E; Ricciardi L; Albanese A; Avenali M; Barone P; Bentivoglio AR; Bonifati V; Bove F; Bonanni L; Brusa L; Cereda C; Cossu G; Criscuolo C; Dati G; De Rosa A; Eleopra R; Fabbrini G; Fadda L; Garbellini M; Minafra B; Onofrj M; Pacchetti C; Palmieri I; Pellecchia MT; Petracca M; Picillo M; Pisani A; Vallelunga A; Zangaglia R; Di Fonzo A; Morgante F; Valente EM;
    Mov Disord; 2020 Nov; 35(11):2106-2111. PubMed ID: 32658388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.